Standard BioTools Inc. (LAB)
$0.66+0.00%Close
SELLCRISIS · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $258M
- Beta
- 1.35
- P/E (TTM)
- -2.86
- Short % float
- 5.89%
- Days to cover
- 2.7
- SI change
- -2.8%
- 1W
- -8.33%
- 1M
- -5.71%
- vs SPY 1W
- -8.19%
- vs SPY 1M
- -8.22%
Industry peers
FMP comparable companies · ranked by market cap
- AVNSSELLAvanos Medical, Inc.$1.2BBULLQ 10$24.99+0.04%
- CGEMSELLCullinan Therapeutics, Inc.$961MCRISISQ 1$15.63-5.69%
- CBLLBUYCeriBell, Inc.$891MBULLQ 1$23.48+3.48%
- BVSSELLBioventus Inc.$865MRECOVERYQ 1$12.77+0.22%
- VREXSELLVarex Imaging Corporation$776MBULLQ 4$18.44-0.05%
- CTKBBUYCytek Biosciences, Inc.$690MBULLQ -8$5.34+0.75%
- KIDSSELLOrthoPediatrics Corp.$577MRECOVERYQ 10$22.48-0.68%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 2
- VALUE
- 6
- GROWTH
- 32
- GARP
- 4
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-10.9%
REV YoY-
ROE-18.2%
EPS YoY-
ROA-13.9%
GROSS49
OP-95
NET-103
[VALUATION]
P/E TTM-2.86
P/E FWD-
SECTOR PE20.34
INDUSTRY PE11.11
P/B0.48
P/FCF-
EV/EBITDA-0.17
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E5.20
ALTMAN Z-
CURR RATIO9.10
ND/EBITDA-
BETA1.35
Company news
FAQ
- What is LOPJLB’s current signal on LAB?
- LOPJLB’s latest quantitative signal on Standard BioTools Inc. (LAB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is LAB in?
- Standard BioTools Inc. (LAB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Standard BioTools Inc. (LAB) do?
- Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, cons…